KR20010041211A - 안지오텐신 ιι 타입 2 수용체 효능제를 포함하는 제약제제 및 그의 용도 - Google Patents
안지오텐신 ιι 타입 2 수용체 효능제를 포함하는 제약제제 및 그의 용도 Download PDFInfo
- Publication number
- KR20010041211A KR20010041211A KR1020007009295A KR20007009295A KR20010041211A KR 20010041211 A KR20010041211 A KR 20010041211A KR 1020007009295 A KR1020007009295 A KR 1020007009295A KR 20007009295 A KR20007009295 A KR 20007009295A KR 20010041211 A KR20010041211 A KR 20010041211A
- Authority
- KR
- South Korea
- Prior art keywords
- angiotensin
- agonist
- type
- receptor
- pharmaceutical formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800550-7 | 1998-02-24 | ||
| SE9800550A SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| PCT/SE1999/000262 WO1999043339A1 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010041211A true KR20010041211A (ko) | 2001-05-15 |
Family
ID=20410283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020007009295A KR20010041211A (ko) | 1998-02-24 | 1999-02-24 | 안지오텐신 ιι 타입 2 수용체 효능제를 포함하는 제약제제 및 그의 용도 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1066048A1 (no) |
| JP (1) | JP2002504516A (no) |
| KR (1) | KR20010041211A (no) |
| CN (1) | CN1291104A (no) |
| AU (1) | AU755949B2 (no) |
| BR (1) | BR9908188A (no) |
| CA (1) | CA2319123A1 (no) |
| EE (1) | EE200000481A (no) |
| HU (1) | HUP0101411A3 (no) |
| ID (1) | ID26639A (no) |
| IL (1) | IL137990A0 (no) |
| IS (1) | IS5594A (no) |
| MX (1) | MXPA00008172A (no) |
| NO (1) | NO20004215L (no) |
| NZ (1) | NZ506188A (no) |
| SE (1) | SE9800550D0 (no) |
| SK (1) | SK11522000A3 (no) |
| WO (1) | WO1999043339A1 (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001043761A2 (en) * | 1999-12-16 | 2001-06-21 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| ATE372987T1 (de) | 2001-05-31 | 2007-09-15 | Vicore Pharma Ab | Trizyklische verbindungen, nützlich als angiotensin ii agonisten |
| CN101193886B (zh) | 2005-04-12 | 2014-08-27 | 维科尔药物公司 | 三环的血管紧张素ii激动剂 |
| EP1869024B1 (en) | 2005-04-12 | 2010-11-10 | Vicore Pharma AB | New tricyclic angiotensin ii agonists |
| ES2582945T3 (es) | 2005-04-12 | 2016-09-16 | Vicore Pharma Ab | Nuevos agonistas bicíclicos de angiotensina II |
| CA2631491C (en) * | 2005-12-14 | 2015-02-24 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
| US20150119329A1 (en) * | 2012-04-16 | 2015-04-30 | New York University | Modulation of angiotensin ii receptors for the prevention and treatment of malaria cerebral |
| WO2016139475A1 (en) | 2015-03-02 | 2016-09-09 | Vicore Pharma Ab | Angiotensin ii receptor agonist for treating pulmonary fibrosis |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
| CN114514032A (zh) | 2019-08-02 | 2022-05-17 | 兰提欧派普有限公司 | 用于治疗癌症的血管紧张素2型(at2)受体激动剂 |
| GB201913603D0 (en) | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| JP2023518948A (ja) | 2020-03-19 | 2023-05-09 | ヴィコール ファルマ アーベー | アンギオテンシンｉｉに関連する疾患、障害又は状態の治療及び／又は予防に有用な新規化合物 |
| GB202004094D0 (en) | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
| GB202006079D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006081D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006074D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202013721D0 (en) | 2020-09-01 | 2020-10-14 | Vicore Pharma Ab | New compounds |
| GB202104038D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| GB202104033D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| JP2024511453A (ja) | 2021-03-23 | 2024-03-13 | ヴィコール ファルマ アーベー | 選択的アンジオテンシンｉｉ受容体リガンド |
| CA3222721A1 (en) | 2021-07-09 | 2023-01-12 | Nadia Nasser PETERSEN | New selective angiotensin ii compounds |
| GB202115303D0 (en) | 2021-10-25 | 2021-12-08 | Vicore Pharma Ab | New formulation |
| GB202201723D0 (en) | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
| WO2023152503A1 (en) | 2022-02-10 | 2023-08-17 | Vicore Pharma Ab | Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5444067A (en) * | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| AU3708295A (en) * | 1994-11-04 | 1996-05-31 | Stefan L. Marklund | Use of receptor agonists to stimulate superoxide dismutase activity |
| SE9501881D0 (sv) * | 1995-05-19 | 1995-05-19 | Astra Ab | New pharmacological use of AII-receptor antagonists |
| US5834432A (en) * | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
| SE9502219D0 (sv) * | 1995-06-19 | 1995-06-19 | Astra Ab | Novel medical use |
-
1998
- 1998-02-24 SE SE9800550A patent/SE9800550D0/xx unknown
-
1999
- 1999-02-24 IL IL13799099A patent/IL137990A0/xx unknown
- 1999-02-24 NZ NZ506188A patent/NZ506188A/xx unknown
- 1999-02-24 HU HU0101411A patent/HUP0101411A3/hu unknown
- 1999-02-24 MX MXPA00008172A patent/MXPA00008172A/es unknown
- 1999-02-24 WO PCT/SE1999/000262 patent/WO1999043339A1/en not_active Application Discontinuation
- 1999-02-24 ID IDW20001909A patent/ID26639A/id unknown
- 1999-02-24 KR KR1020007009295A patent/KR20010041211A/ko not_active Application Discontinuation
- 1999-02-24 AU AU27537/99A patent/AU755949B2/en not_active Ceased
- 1999-02-24 SK SK1152-2000A patent/SK11522000A3/sk unknown
- 1999-02-24 JP JP2000533135A patent/JP2002504516A/ja active Pending
- 1999-02-24 CN CN99803230A patent/CN1291104A/zh active Pending
- 1999-02-24 EP EP99908017A patent/EP1066048A1/en not_active Withdrawn
- 1999-02-24 BR BR9908188-1A patent/BR9908188A/pt not_active IP Right Cessation
- 1999-02-24 CA CA002319123A patent/CA2319123A1/en not_active Abandoned
- 1999-02-24 EE EEP200000481A patent/EE200000481A/xx unknown
-
2000
- 2000-08-21 IS IS5594A patent/IS5594A/is unknown
- 2000-08-23 NO NO20004215A patent/NO20004215L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2319123A1 (en) | 1999-09-02 |
| BR9908188A (pt) | 2000-10-24 |
| AU755949B2 (en) | 2003-01-02 |
| EE200000481A (et) | 2002-02-15 |
| MXPA00008172A (es) | 2002-06-21 |
| NO20004215L (no) | 2000-09-18 |
| EP1066048A1 (en) | 2001-01-10 |
| IL137990A0 (en) | 2001-10-31 |
| NO20004215D0 (no) | 2000-08-23 |
| WO1999043339A1 (en) | 1999-09-02 |
| SK11522000A3 (sk) | 2001-04-09 |
| NZ506188A (en) | 2003-04-29 |
| ID26639A (id) | 2001-01-25 |
| SE9800550D0 (sv) | 1998-02-24 |
| IS5594A (is) | 2000-08-21 |
| AU2753799A (en) | 1999-09-15 |
| JP2002504516A (ja) | 2002-02-12 |
| CN1291104A (zh) | 2001-04-11 |
| HUP0101411A3 (en) | 2002-11-28 |
| HUP0101411A2 (hu) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20010041211A (ko) | 안지오텐신 ιι 타입 2 수용체 효능제를 포함하는 제약제제 및 그의 용도 | |
| CA2321700C (en) | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein | |
| KR101186029B1 (ko) | 신경병증성 당뇨병성 족부 궤양을 치료하기 위한트레프로스티닐의 용도 | |
| DK2683393T3 (en) | TRIPEPTIME COMPOSITIONS AND THEIR USE IN TREATING DIABETES | |
| AU2013202269A1 (en) | Compositions and methods for the treatment of fibrosis and fibrotic diseases | |
| Okuno et al. | SQ 14, 225 attenuates the vascular response to norepinephrine in the rat mesenteric arteries | |
| CA2590804C (en) | Use of bombesin/gastrin-releasing peptide antagonist for the treatment of sepsis, acute lung injury, septic shock or rheumatoid arthritis | |
| Stöckmann et al. | Long-term treatment of patients with endocrine gastrointestinal tumours with the somatostatin analogue SMS 201-995 | |
| Leslie et al. | Absence of blood-pressure lowering effect of captopril in anephric patients. | |
| AU706660B2 (en) | Use of certain angiotensin II type I receptor antagonists for dyspeptic symptons in mammals including man | |
| JPS60231618A (ja) | 胃腸潰瘍の治癒促進用製剤組成物 | |
| KR101153571B1 (ko) | 테나토프라졸 및 히스타민 ｈ2-수용체 길항제를 배합한제약 조성물 | |
| CZ20003080A3 (cs) | Farmaceutický prostředek obsahující agonistu receptoru pro angiotensin II 2.typu a jeho použití | |
| US7452877B2 (en) | Methods for treating digestive functional pathologies | |
| Brunner et al. | The clinical application of converting enzyme inhibitors | |
| US20080286355A1 (en) | Protease Inhibitors For the Treatment of Digestive Pathologies | |
| RU2147884C1 (ru) | Способ лечения язвенной болезни желудка и двенадцатиперстной кишки | |
| RU2039563C1 (ru) | Способ лечения больных рожей | |
| Johnston et al. | Pharmacology of agents acting on the renin-angiotensin system | |
| EP2421547A1 (en) | Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| N231 | Notification of change of applicant | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |